Ranluspec
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ranluspec, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: EMA Authorised: Ranluspec (ranibizumab) — Lupin Europe GmbH
1 regulatory and trial event tracked for Ranluspec, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: EMA Authorised: Ranluspec (ranibizumab) — Lupin Europe GmbH